NEOG insider reports stock and options grants at $6.07
Rhea-AI Filing Summary
Neogen Corporation (NEOG) director reported equity grants. On 10/23/2025, the insider acquired 19,769 shares of common stock at $6.07 per share, bringing direct beneficial ownership to 43,757 shares. The filer also reported a grant of options to buy 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. According to the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversaries of the grant date.
Positive
- None.
Negative
- None.
Insights
Routine director equity grants; neutral impact.
A Neogen director reported standard equity awards dated 10/23/2025: 19,769 common shares at $6.07 and options for 50,814 shares with a $6.07 exercise price, expiring 10/23/2035.
The footnote states options and RSUs vest in equal annual installments over three years, which spreads potential share delivery over time and ties value to service-based vesting.
This filing records compensation-related grants rather than open-market buying or selling. Actual impact on float depends on future vesting and exercises.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 50,814 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,769 | $6.07 | $120K |
Footnotes (1)
- F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
FAQ
What insider transaction did NEOG report on Form 4?
What are the key terms of the NEOG option grant?
How do the NEOG equity awards vest?
Was the NEOG transaction under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.